Colchicine for Skin Involvement in Immunoglobulin A Vasculitis: A Single-Center Case Series and Review of the Literature

Key Points

• This study aims to assess the effectiveness and safety of colchicine for treating skin involvement in immunoglobulin A vasculitis.
• Reviewed a single-center case series of patients with IgAV
• Administered colchicine for persistent or severe skin symptoms
• Evaluated outcomes based on patient response to treatment
• Colchicine was found to be a safe treatment
• Demonstrated effectiveness in managing persistent cutaneous manifestations
• Supportive of further controlled studies for validation